Heterogeneity of class I beta-lactamase expression in clinical isolates of Pseudomonas aeruginosa
- PMID: 3149885
- PMCID: PMC176040
- DOI: 10.1128/AAC.32.12.1893
Heterogeneity of class I beta-lactamase expression in clinical isolates of Pseudomonas aeruginosa
Abstract
Expression of chromosomal beta-lactamase was examined in 85 clinical isolates of Pseudomonas aeruginosa. beta-Lactamase assays with and without cefoxitin induction revealed four phenotypes of enzyme expression: low basal, inducible; moderate basal, inducible; moderate basal, constitutive; and high basal, constitutive. The isoelectric points of the major beta-lactamase bands were 9.4, 9.2, and 8.4. These results indicate that there is a limited heterogeneity in expression of chromosomal beta-lactamase of P. aeruginosa.
Similar articles
-
[Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase].Enferm Infecc Microbiol Clin. 1996 Apr;14(4):211-4. Enferm Infecc Microbiol Clin. 1996. PMID: 9044634 Spanish.
-
[Relationship between beta-lactamase activity of clinical strains of Pseudomonas pyocyanea and their resistance to penicillins].Antibiotiki. 1976 Apr;21(4):344-9. Antibiotiki. 1976. PMID: 818952 Russian.
-
Mutants of Pseudomonas aeruginosa with impaired -lactamase inducibility and increased sensitivity to -lactam antibiotics.J Gen Microbiol. 1973 Jun;76(2):455-7. doi: 10.1099/00221287-76-2-455. J Gen Microbiol. 1973. PMID: 4198718 No abstract available.
-
The control of class I beta-lactamase expression in Enterobacteriaceae and Pseudomonas aeruginosa.J Antimicrob Chemother. 1991 Aug;28(2):167-72. doi: 10.1093/jac/28.2.167. J Antimicrob Chemother. 1991. PMID: 1778849 Review. No abstract available.
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
Cited by
-
High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment.Antimicrob Agents Chemother. 1992 Jan;36(1):71-6. doi: 10.1128/AAC.36.1.71. Antimicrob Agents Chemother. 1992. PMID: 1590704 Free PMC article.
-
An SHV-derived extended-spectrum beta-lactamase in Pseudomonas aeruginosa.Antimicrob Agents Chemother. 1999 May;43(5):1281-4. doi: 10.1128/AAC.43.5.1281. Antimicrob Agents Chemother. 1999. PMID: 10223953 Free PMC article.
-
Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa.Antimicrob Agents Chemother. 1993 May;37(5):962-9. doi: 10.1128/AAC.37.5.962. Antimicrob Agents Chemother. 1993. PMID: 8517722 Free PMC article.
-
Potential impact of the VITEK 2 system and the Advanced Expert System on the clinical laboratory of a university-based hospital.J Clin Microbiol. 2001 Jul;39(7):2379-85. doi: 10.1128/JCM.39.7.2379-2385.2001. J Clin Microbiol. 2001. PMID: 11427542 Free PMC article.
-
Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Clin Microbiol Rev. 2009 Oct;22(4):582-610. doi: 10.1128/CMR.00040-09. Clin Microbiol Rev. 2009. PMID: 19822890 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources